Objective: Magnetic resonance (MR) thermography-guided laser interstitial thermal therapy, or stereotactic laser ablation (SLA), is a minimally invasive alternative to open surgery for focal epilepsy caused by cerebral cavernous malformations (CCMs). We examined the safety and effectiveness of SLA of epileptogenic CCMs. Methods: We retrospectively analyzed 19 consecutive patients who presented with focal seizures associated with a CCM. Each patient underwent SLA of the CCM and adjacent cortex followed by standard clinical and imaging follow-up. Results: All but one patient had chronic medically refractory epilepsy (median duration 8 years, range 0.5-52 years). Lesions were located in the temporal (13), frontal (five), and parietal (one) lobes. CCMs induced magnetic susceptibility artifacts during thermometry, but perilesional cortex was easily visualized. Fourteen of 17 patients (82%) with >12 months of follow-up achieved Engel class I outcomes, of which 10 (59%) were Engel class IA. Two patients who were not seizure-free from SLA alone became so following intracranial electrode-guided open resection. Delayed postsurgical imaging validated CCM involution (median 83% volume reduction) and ablation of surrounding cortex. Histopathologic examination of one previously ablated CCM following open surgery confirmed obliteration. SLA caused no detectable hemorrhages. Two symptomatic neurologic deficits (visual and motor) were predictable, and neither was permanently disabling. Significance: In a consecutive retrospective series, MR thermography-guided SLA was an effective alternative to open surgery for epileptogenic CCM. The approach was free of hemorrhagic complications, and clinically significant neurologic deficits were predictable. SLA presents no barrier to subsequent open surgery when needed.
imaging (MRI), CCMs appear heterogeneously hyperintense with a surrounding hypointense rim of hemosiderinladen parenchyma. CCMs are relatively common (incidence of 0.16%
3 ) and carry a 5-year symptomatic hemorrhage risk of 15.8%. [4] [5] [6] [7] CCMs cause gliosis and neuronal irritation 8, 9 ; up to 70% of patients with supratentorial CCMs present with seizures, and 40%-50% of these cases become medically refractory. 2, 10, 11 Surgical resection of a CCM and surrounding cortex is considered critical to achieving seizure freedom. [4] [5] [6] Stereotactic laser ablation (SLA) using coagulates tissue at 50°C-90°C while making use of real-time MR thermography to visualize collateral structures to be protected. 12, 13 SLA provides an alternative to open epilepsy surgery for a variety of brain pathologies, [13] [14] [15] [16] [17] [18] [19] and provides neurocognitive outcomes superior to those of traditional open resection for medial temporal lobe epilepsy. [20] [21] [22] We previously described the technical feasibility of SLA of CCMs. 23 Herein we report the safety, clinical effects, and imaging features of 19 patients who underwent SLA of CCMs, and an example of postablation histopathologic findings.
| METHODS

| Patient selection
Following our first 5 successive patients, 23 additional patients underwent SLA between July 2012 and September 2018 at a single institution. Indication for surgery was the presence of a CCM causing drug-resistant seizures, except for Patient 6, who sought early intervention to discontinue antiepileptic medications. 24 Brain MRI in each case showed a characteristic "popcorn" appearance with a rim of hypointensity on T2-weighted sequences and prominent blooming artifact on susceptibility-weighted sequences indicating the presence of hemosiderin. In all but Patient 6, additional preoperative evaluation included neuropsychometric testing, long-term video-electroencephalography (EEG), and 18-fluorodeoxyglucose positron-emission tomography (FDG-PET). In addition, Patient 16, with a lesion in the dominant postcentral gyrus/sulcus, underwent functional MRI for language and stereo-EEG (SEEG) with cortical mapping by direct electrical stimulation. Patient 17, with a lesion in the nondominant precentral gyrus/sulcus, underwent functional MRI for motor localization and awake motor testing during ablation.
All patients elected to undergo laser ablation as the primary surgical intervention over open resection and signed informed surgical consent. The first 5 patients were told that application of SLA to CCM was novel, untested, and carried an uncertain risk of bleeding. 23 Thereafter, all patients were apprised of accruing evidence of safety from our initial experience. All patients were specifically warned that bleeding, unanticipated neurologic deficits, or need for additional surgery could occur. This retrospective review of clinical data for research was approved by the Emory University Institutional Review Board.
| Stereotactic surgical procedure
All patients underwent general anesthesia except for Patient 17, who was treated while awake. At the beginning of each procedure, patients were administered intravenous antibiotic for infection prophylaxis. Most were also administered intravenous dexamethasone, and many received levetiracetam. Ablations were performed by one of 2 surgeons (JTW or REG) using the Visualase Thermal Therapy System (Medtronic, Inc.), which utilizes laser energy (up to 15W, 980 nm) delivered through an optical fiber inside a saline-cooled cannula (1.65 mm outer diameter) to produce rapid and localized tissue injury. 12 For the minority of cases, we used a traditional stereotactic frame (CosmanRoberts-Wells [CRW] stereotactic frame, Integra Neurosciences), with the Stealth S7 (Medtronic, Inc.) Framelink targeting software, with placement of the stereotactic bolt in the operating room followed by transport to the MR suite for treatment. For the majority of cases, we used the ClearPoint MRI-guided Neuro Navigation Platform (MRI Interventions), performing the entire procedure within an interventional MRI suite. The relative advantages of each workflow are detailed elsewhere. 13, 25 In all cases, we performed final insertion of the device into the body of the CCM only with the patient positioned in the MRI scanner, followed by immediate imaging. predict cumulative tissue damage during the ablation. Postablation MRI, including diffusion-weighted, T2 inversion recovery, and contrast-enhanced T1 sequences confirmed total area of ablation. When the ClearPoint platform was used, a second ablation track was made to maximize the treatment area when judged important. Following each procedure, the device was completely removed, the surgical site closed with a dissolvable suture, general anesthesia was reversed, and the patient was extubated. Patients were admitted to a regular hospital ward until discharge. Patients were instructed to remain on antiepileptic medications and weaned at the discretion of a treating neurologist.
| Clinical follow-up and analysis
At each return visit, patients were queried as to the occurrence of seizures, any adverse effects, and medication status. A small minority provided follow-up by documented phone interviews with clinical staff. Seizure outcomes are reported using the Engel classification scheme. 26 All but Patients 18 and 19 had >12 months of follow-up after ablation. Patients not rendered free of disabling seizures by ablation alone were considered eligible for additional surgical procedures. Kaplan-Meier survival analysis was performed with respect to postoperative recurrence of any debilitating seizure occurring more than 4 weeks postablation (consistent with the Engel classification scheme), and censorship occurred at each subject's last follow-up.
| Image follow-up and processing
Volumes were calculated using OsiriX (Pixmeo) by tracing contours in each slice along the dimension of the thinnest cut. Preablation CCM volumes were measured using the T2-weighted MRI, tracing hypointense hemosiderin rims. Immediate postablation volumes were measured by tracing the enhancing borders of gadolinium-contrasted T1-weighted images (thermal injury zone). At last available follow-up imaging, the residual CCM volume was traced around the hypointense residual nodule on T2-weighted MRI.
| Pathologic examination
Patients 3 and 16 underwent open resection after ablation. Although the ablation from Patient 3 was not identified, a nodular structure corresponding to the ablated CCM from Patient 16 was resected, fixed in formalin, embedded in paraffin, sectioned at 4 μm, and stained with hematoxylin and eosin (H&E). Immunohistochemistry was performed using antisera directed against glial fibrillary acidic protein (GFAP; Dako; Polyclonal, no dilution) and MIB1/Ki67 (Dako; MIB-1 1:80 dilution).
| RESULTS
| Preoperative characteristics
We performed SLA on 19 sequential patients (9 female) presenting with focal (motor or cognitive) seizures with or without progression to secondary tonic-clonic activity and a clinically correlating CCM (Table 1 , Figures 1-3 We found that because of the paramagnetic effects of concentrated blood products within CCMs, intraoperative thermal (gradient echo) imaging had signal dropout within the boundaries of larger lesions, thus delaying the real-time estimation of irreversible damage ( Figures 1E-F and 3B-C) . However, since the perilesional cortex surrounding each CCM imaged normally, overall monitoring of the extent of the intended ablation was executed without technical difficulty. Immediate postablation T2 fluid-attenuated inversion recovery (FLAIR), diffusion-weighted imaging (DWI), and postcontrast T1-weighted sequences verified intended ablations (Figures 1-3 ). 
| Stereotactic laser ablation
T A B L E 1 Preoperative patient and lesion characteristics
| Adverse events
We observed no hemorrhagic complications following initial cannula insertion to target depth, during ablation, or following withdrawal of the laser cannula (Table 2) . Moreover, no hemorrhagic complications resulted from additional trajectories in three patients (Patients 12, 16, and 18). Seventeen of 19 patients were discharged on the first postoperative day, with 2 (Patients 4 and 5) being discharged on the second day. In Patient 11, the ablation of a CCM in the posterior hippocampus also extended into the temporal lobe white matter. This ablation caused a partial right superior quadrantanopia, likely due to injury of the optic radiation (Meyer's loop). This deficit was not disabling, as the patient recovered subjectively and subsequently obtained a license to drive. Patient 17, who underwent awake ablation in order to monitor motor function, began to develop intrinsic weakness of the nondominant hand, and ablation was then discontinued, in a manner analogous to the accepted approach for awake open surgery in eloquent cortex. The patient underwent occupational therapy, returned to work as a practicing dentist within 1 week, and denied any functional disability at 12 months of follow-up. Patient 16 had no subjective deficits following ablation, but did sustain expected perioral sensory disturbance from open resection of the lateral postcentral gyrus, which has been persistent but nondisabling.
There were no readmissions related to surgery or seizures, and no other delayed complications were identified. Neuropsychological outcomes of laser ablation across different brain regions, collected in a subset of patients that chose to participate in a prospective research study with an independent consent process, will be the subject of future investigation.
| Seizure outcomes
Follow-up was obtained for a mean 30.6 ± 12.6 SD months (median 32, range 2-49, Table 2 ). Kaplan-Meier analysis revealed no seizure recurrence beyond 6 months after the perioperative period in the first 17 patients having >12 months follow-up ( Figure 4A follow-up, 14 of 17 patients (82%) were free of disabling seizures from ablation alone (Engel class I) with 10 (59%) having been completely seizure-free from the time of surgery (Engel class 1A)( Figure 4B ). In addition, 9 of 16 patients with >24 months follow-up (56%) were prescribed a reduced number of medications and 5 (31%) were off all antiepileptic medications at last follow-up (Tables 1 and 2) . Patients 18 and 19 were not assigned an Engel classification due to short follow-up postablation. Patients 3, 8, and 16 failed to achieve freedom from disabling seizures after ablation alone (Table 2) 
ictal electrocorticography-guided topectomy of the inferior postcentral gyrus (in which the site of her prior CCM ablation was identified, Figure 3F ). This caused continuous perioral/tongue dysesthesia that was not disabling, and she remained completely seizure-free at 12 months after resection.
| Imaging outcomes
Lesions were in proximity to either an apparent developmental venous anomaly (14/19) or to another contrast-enhancing vessel or pial/dural interface (5/19)( Table 1 ). The mean preoperative volume of CCMs in this series was 0.7 ± 0.6 cm 3 (range 0.1-2.5 cm 3 ), whereas immediate postablative contrasted T1-weighted images showed a mean ablation zone of 3.8 ± 2.6 cm 3 (range 0.6-10.0 cm 3 )( Table 2 , Figures 1-3 ).
Of the patients with follow-up imaging (14/19) at a mean In general, delayed postablation imaging reveals T2 hypointensity within the involuted CCM and surrounding T2 hyperintensity 18 ± 10 (median 15, range 6-42) months postablation, we observed that ablated CCMs took on a nodular T2 hypointense appearance (Figures 1-3 ) and decreased volumes ( Table 2 , mean volume 0.2 ± 0.3 cm 3 ). Involuting CCMs were surrounded by T2-hyperintense ablation cavities (encephalomalacia). Patient 17, with a CCM adjacent to primary motor cortex who underwent awake partial ablation, did not show encephalomalacia (Figure 2 ). We observed no delayed hemorrhages or unexpected postablation findings.
| Pathology
Patients 3 and 16 underwent additional open resection after laser ablation. In Patient 3, histopathologic examination of tissue resected from the epileptogenic zone, which included the prior ablation, revealed cortex with reactive gliosis, but without definitive features of a cavernous malformation. This absence may have resulted from insufficient sampling, or from prior complete obliteration of the relatively small lesion in this case. In Patient 16, the location of prior CCM (nodular tan-colored friable structure in Figure 3F , arrow) was grossly verified, dissected, and sent as an isolated specimen.
Microscopically, standard H&E staining of the specimen revealed postsurgical reactive type changes, but no definite residual/recurrent cavernous malformation. The sample contained primarily reactive astrogliosis, hemosiderin-laden macrophages (indicating prior hemorrhage), inflammatory infiltration, scattered calcifications, and areas of apparent fibrotic/sclerotic arachnoid mater ( Figure 2G ). Instead of dilated thin-walled vessels, we observed arachnoid tissue containing collapsed hyalinized vessels. Immunohistochemistry demonstrated both a low MIB1/Ki67 proliferation index (<1%) and a reactive gliosis, as highlighted by GFAP stain (not shown). For comparison, the typical microscopic features of a resected CCM from an unrelated, nonablated control patient shows dilated thin-walled vessels ( Figure 2H ). We interpret our findings to be consistent with obliteration of the presumed CCM.
| DISCUSSION
Recent studies have demonstrated the use of SLA in varied locations and pathologic entities associated with epilepsy, In cases of early failure to maintain seizure freedom and transition to open surgery before 12 months, the outcome after laser ablation alone was imputed forward to operationally represent the lower Engel class at 12 months. and our series selected for subjects presenting with epilepsy rather than symptomatic hemorrhage. Indeed, this series does not include any patient with a deep/brainstem lesion, thunderclap headaches, neurologic deficits, or familial cavernous malformations. Our previous technical report demonstrated the feasibility of stereotactic ablation of CCMs. 23 The present study of 19 patients with epilepsy further supports the relative safety of the approach, as hemorrhages were not observed, and neurologic deficits induced by ablation were expected for location and were ultimately nondisabling. Hospital lengths of stay were brief, and patients achieved a high rate of long-term seizure control.
| Comparison of SLA to other interventions
Ictal electrocorticography-guided resection of the CCM and surrounding cortex is considered the gold standard for epilepsy management 35 yielding seizure control in 70%-80% of patients. 4, [36] [37] [38] [39] [40] [41] [42] Larger resections (ie, lobectomies) and frontal/insular locations have been associated with the best seizure outcomes. 36 However, microsurgery for CCMs requires an incision and craniotomy, risks unintended collateral injury (especially in deep or eloquent regions), 3 and lobectomies induce wider neurocognitive deficits. [20] [21] [22] Stereotactic radiosurgery (SRS) is an incisionless alternative to open surgery that yields rates of seizure freedom generally below those of open resection. In one large retrospective cohort, only 53% of patients were seizure-free (n = 26/49), and patients with more disabling complex partial seizures fared worse with respect to seizure control than did those with simple partial seizures. 39 SRS for CCM is also associated with a protracted temporal course and symptomatic radiation necrosis, especially at doses used to treat seizures. 3, [43] [44] [45] By comparison, SLA is minimally invasive and immediately effective in most cases. Our high rate of seizure control (82% Engel class I) is comparable to that of open surgery, and in 2 patients (3 and 16) who were not initially rendered seizure-free, prior ablation proved to be no barrier to successful open surgery. Nor did prior interventions prevent ablation, as some patients had already undergone SRS and vagus nerve stimulation (VNS). Although neuropsychological outcomes were not detailed in this report, such results in a large number of ablations across diverse brain locations is the subject of a different study currently in preparation.
Although there were no hemorrhages, we observed 2 symptomatic neurologic deficits resulting from ablations, and another from a subsequent open resection. In Patient 11, a partial superior quadrantanopia resulted from ablating a posterior hippocampal CCM near the optic radiation. Notably, any standard open approach to this lesion would likely transgress the optic radiation, and superior quadrantanopia is a known risk of standard open temporal lobe surgery. In our patient, this partial visual field deficit was nondisabling (noticed only when playing basketball), and he subsequently obtained a license to drive. In Patient 17, a neurologic deficit (increased nondominant hand weakness) was an expected result of ablating a CCM in the precentral gyrus, and the ablation was carried out with the patient awake in order to monitor and minimize disability. He quickly returned to work as a dentist and reported complete functional recovery by 2 months. Notably, Patient 16 underwent awake open surgery and likewise sustained an expected deficit from resection in the lateral postcentral gyrus (nondisabling perioral sensory disturbance). Epilepsy surgery by any method is by nature destructive to cortex, and when performed in eloquent cortex, the chance for seizure freedom must be weighed against the risks of symptomatic neurologic deficits.
| Study limitations
Although this series includes all presenting cases of medically refractory epilepsy associated with a CCM at a high-volume epilepsy center over a 6-year period, it still represents a relatively small retrospective review of a nonhomogeneous real-world cohort in which the outcome of any one patient will significantly affect group results. Nevertheless, our results align with the expected effectiveness of more extensive open microsurgery. Ideally, a larger series and a cohort design comparing SLA against gold standard open microsurgery would help evaluate the relative risks and benefits of SLA, but studies of this design have been prohibitively difficult to enroll, rendering statistical conclusions impractical. 44 Despite limitations, this series suggests relative safety and effectiveness of this procedure as a necessary first step toward future studies.
| Technical considerations
The Visualase Thermal Therapy System generates an ablation volume that is time-and power-dependent, and an ablation diameter may generally reach >2 cm if unlimited by anatomic boundaries such as pia or ventricles. In 3 patients, however, following completion of the initial ablation trajectory, the surgeon judged intraoperatively that the irregular size and shape of the target with its adjacent hemosiderin-laden cortex called for more extensive therapy. In these cases, use of an MRI-guidance platform (ClearPoint) facilitated redirection and execution of a second ablation trajectory during the same surgical session. SLA performed with other workflows utilizing a stereotactic bolt provides less flexibility. In this setting, the surgeon may consider initial insertion of more than one bolt to support additional ablation trajectories. Unlike other ablation targets, we observed that static blood products within CCMs can impair gradient echo-based thermography. The resulting signal dropout within portions of a CCM may degrade the thermal-anatomic correlation utilized to optimize safety. Thus, CCMs require additional vigilance, and the surgeon must rely more upon prior empirical experience with spatial-temporal ablation dynamics. Because temperatures within a CCM have greater potential for inaccuracy, additional care should be taken to use conservative laser power settings (eg, <12-13 W). Once ablation volume extends outside the CCM, thermal-anatomic correlation becomes more readily apparent, and thermography is sufficient for monitoring treatment of both perilesional epileptogenic cortex and off-target tissue at risk.
Delayed postablation imaging, obtained in the majority of subjects, showed a central T2-hypointense nodule circumscribed by T2 hyperintensity. These findings are consistent with a parenchymal ablation cavity (encephalomalacia) around the central involuting CCM. No subject showed postoperative evidence of CCM growth or hemorrhage. Indeed, histopathologic examination of an ablated CCM found no remaining pathognomonic features. Together, these findings support the notion that SLA can obliterate structural and cellular features of CCMs.
Our observations may not necessarily apply to all cavernous malformations. For instance, a CCM can come to clinical attention not from epilepsy, but from a natural history of hemorrhage and growth, causing headaches or neurologic deficits. Subcortical, brainstem, and spinal cord cavernous malformations provide additional management challenges with respect to the sensitivity of surrounding neural structures. In addition, familial CCMs may present with multiple lesions, varied neurologic sequelae, and greater risk of recurrence. None of the subjects in this series had a personal history of symptomatic bleeding. Thus, greater caution before using SLA for a deep-seated CCM, multifocal or familial CCM, and/or lesions with aggressive natural histories may be warranted, especially because the tissue temperatures achieved during laser interstitial thermal therapy are well below those achieved by direct current electrocautery instruments and unlikely to provide direct hemostasis. 46 In patients presenting with acute hemorrhage and neurologic deficits related to mass effect, strong consideration should still be given to open microsurgery.
| CONCLUSION
Real-time MR thermography-guided SLA is a minimally invasive alternative to open microsurgery that can definitively ablate both the CCM and associated epileptic cortex while potentially minimizing collateral injury to offtarget structures. SLA of CCMs is feasible, and when compared to open surgery, may be as effective for epilepsy and as tolerable or more tolerable. SLA thus holds promise as a first-line, minimally invasive therapy for the management of epilepsy associated with CCMs, but larger case-controlled long-term studies are needed.
